7 completed, 2 unknown, 1 not yet recruiting, 1 recruiting. 4 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Terminated 1 |
Follow Diabetes Insipidus, Nephrogenic: new trials by email Literature Review of Diabetes Insipidus, Nephrogenic trials Research Report on Diabetes Insipidus, Nephrogenic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Arginin-stimulated Copeptin in Polyuria-polydipsia Syndrome in Children Measure of Basal Copeptin level, Measure of arginine-stimulated copeptin, IRM - Primary Polydipsia, Central Diabetes Insipidus | Not applicable | Not yet recruiting | Assistance Publique Hopitaux De Marseille | 155 | 2025-03-01 | 2025-02-13 |
| Baby Detect : Genomic Newborn Screening Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1 | Completed | Centre Hospitalier Universitaire de Liege | 6824 | 2022-09-01 | 2025-08-12 | |
| Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration PB - Autosomal Dominant Polycystic Kidney Disease, Nephrogenic Diabetes Insipidus | Phase 2 | Completed | Mayo Clinic | 36 | 2022-09-01 | 2026-01-27 |
| Decline in Renal Concentration Ability in Lithium Treated Patients Deamino Arginine Vasopressin (dDAVP) - Lithium Toxicities, Bipolar Disorder | Unknown | Radboud University Medical Center | 51 | 2022-05-01 | 2022-04-01 | |
| Nephrogenic Diabetes Insipidus During Prolonged Sevoflurane Sedation in the ICU: a Retrospective Analysis Sevoflurane - Nephrogenic Diabetes Insipidus | Completed | Universitair Ziekenhuis Brussel | 1000 | 2021-05-26 | 2023-04-27 | |
| Atorvastatin for the Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus Atorvastatin - Lithium Use, Nephrogenic Diabetes Insipidus | Phase 2 | Completed | Lady Davis Institute | 60 | 2017-07-13 | 2020-09-16 |
| Metformin and Congenital Nephrogenic Diabetes Insipidus Metformin - Diabetes Insipidus | Phase 1 | Terminated | Emory University | 2 | 2015-09-01 | 2018-07-17 |
| National Registry of Rare Kidney Diseases Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis | Recruiting | UK Kidney Association | 35000 | 2009-11-06 | 2023-10-04 | |
| Stress Management Therapy for Meniere's Disease Lifestyle - Meniere's Disease, Stress | Not applicable | Unknown | Osaka University | 200 | 2009-01-01 | 2010-04-06 |
| Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus sildenafil, calcitonin, hydrochlorothiazide/amiloride - Nephrogenic Diabetes Insipidus | Not applicable | Completed | University of Colorado, Denver | 4 | 2007-05-01 | 2018-02-12 |
| Vasopressin and V2 Receptor in Meniere's Disease vasopressin, V2 receptor and cyclic AMP - Meniere Disease | Not applicable | Completed | Osaka University | 135 | 1998-04-01 | 2016-03-29 |
| Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus chlorothiazide - Diabetes Insipidus, Nephrogenic | Completed | National Center for Research Resources (NCRR) | 1995-09-01 | 2005-06-24 |
Diabetes Insipidus (5) · Cystinosis (2) · Hyperoxaluria, Primary (2) · Meniere Disease (2) · Nephritis, Hereditary (2) · Polycystic Kidney, Autosomal Dominant (2) · Pseudohypoaldosteronism (2) · 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1) · 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1) · Acidemia, isovaleric (1) · Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1) · Adenine phosphoribosyltransferase deficiency (1) · Adrenal Hyperplasia, Congenital (1) · Adrenoleukodystrophy (1)
Female Urogenital Diseases (12) · Female Urogenital Diseases and Pregnancy Complications (12) · Kidney Diseases (12) · Male Urogenital Diseases (12) · Urogenital Diseases (12) · Urologic Diseases (12) · Diabetes Insipidus (7) · Endocrine System Diseases (7) · Pituitary Diseases (6) · Pathological Conditions, Signs and Symptoms (5) · Pathologic Processes (4) · Abnormalities, Multiple (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3)
Atorvastatin (1) · Calcitonin (1) · Chlorothiazide (1) · Cyclic AMP (1) · Indomethacin (1) · Metformin (1) · Receptors, Vasopressin (1) · Sevoflurane (1) · Sildenafil Citrate (1) · Vasopressins (1) · amiloride, hydrochlorothiazide drug combination (1) · salmon calcitonin (1)
Osaka University (2) · Assistance Publique Hopitaux De Marseille (1) · Centre Hospitalier Universitaire de Liege (1) · Emory University (1) · Lady Davis Institute (1) · Mayo Clinic (1) · National Center for Research Resources (NCRR) (1) · Radboud University Medical Center (1) · UK Kidney Association (1) · Universitair Ziekenhuis Brussel (1) · University of Colorado, Denver (1)
United States (3) · Belgium (2) · Japan (2) · Canada (1) · Denmark (1) · France (1) · Netherlands (1) · United Kingdom (1)
Tadashi Kitahara, M.D.,Ph.D. (2) · Fouad Chebib, MD (1) · Gary L. Robertson (1) · Hiroshi Kiyama, Ph.D. (1) · Larry Greenbaum, MD, PhD (1) · Laurent Servais (1) · Melissa A Cadnapaphornchai, MD (1) · Soham F Rej, MD, M.Sc. (1) · T. Nijenhuis (1) · Takeshi Kubo, M.D.,Ph.D. (1) · Titilayo Ilori, MD (1)